The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Axial Spondyloarthritis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / HCQ Debate: Should Dose Be No More Than 5 mg/kg in All SLE Patients?

HCQ Debate: Should Dose Be No More Than 5 mg/kg in All SLE Patients?

September 20, 2018 • By From the College

  • Tweet
  • Email
Print-Friendly Version / Save PDF
Yongcharoen_kittiyaporn / shutterstock.com

Yongcharoen_kittiyaporn / shutterstock.com

Multiple studies show that hydroxychloroquine (HCQ) has many benefits in systemic lupus erythematosus (SLE), including cardiovascular benefits, such as reducing coronary artery and thrombosis risks. HCQ can prevent disease flares, including in renal and central nervous system lupus, and is the only drug shown to prolong survival in lupus. However, guidelines released in 2016 by the American Academy of Ophthalmology (AAO) highlight potential retinal risks from long-term use of HCQ. These guidelines recommend the use of newly available screening tests for retinopathy and limitations on the dose of HCQ, causing confusion among rheuma­tologists regarding the guidelines, the screening tests and their interpretation.

You Might Also Like
  • Rheumatologists Debate Hydroxychloroquine Dosing Guidelines for Lupus
  • Hydroxychloroquine Risk-Benefit Discussion, & a Handy Dosage App
  • California Rheumatology Alliance 2013 Meeting: Rheumatologists Advised to Drop Prednisone Maintenance Therapy in Lupus Patients
Explore This Issue
September 2018
Also By This Author
  • Last Call for 2019 RheumPAC Contributions

Is the dose of HCQ ≤5 mg/kg real body weight recommended by the AAO appropriate? This year’s debate by experts in the field will lead to greater of understanding of both the risks and benefits of HCQ in SLE and the role of the AAO guidelines across disciplines. In this session, Nathalie Costedoat-Chalumeau, MD, PhD, of the Cochin University Hospital, Paris, will introduce the topic. Michelle Petri, MD, MPH, professor of medicine and director of the Lupus Center at Johns Hopkins will review the many benefits of HCQ and present the position that the new guidelines are inappropriate. James T. Rosenbaum, MD, the Edward E Rosenbaum Professor of Inflammation Research at Oregon Health & Science University and the Richard Chenoweth Chair of Ophthalmology at Legacy Devers Eye Institute, both in Portland, Ore., will take the opposing viewpoint and discuss the rationale for the new guidelines and why the AAO deems them necessary.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dont miss 2018 Great Debate

Guidelines for SLE: HCQ Dose Should Be No More than 5 mg/kg in All Patients
Sunday, Oct. 21
2:30–4 p.m.
McCormick Place
Chicago

Filed Under: From the College, Safety, SLE (Lupus) Tagged With: 2018 ACR/ARHP Annual Meeting, dosage, HCQ, HYDROXYCHLOROQUINEIssue: September 2018

You Might Also Like:
  • Rheumatologists Debate Hydroxychloroquine Dosing Guidelines for Lupus
  • Hydroxychloroquine Risk-Benefit Discussion, & a Handy Dosage App
  • California Rheumatology Alliance 2013 Meeting: Rheumatologists Advised to Drop Prednisone Maintenance Therapy in Lupus Patients
  • Cardiovascular Disease Rate Differs Between SLE Patients of Different Races, Ethnicities

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2022 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)